- IV Curso de parasitologia voltado à saúde pública – 02 a 13 set. 2019 - XVII Congresso de enfermagem - 09 a 13 set. 2019 - 8º Simbravisa - 8º Simpósio Brasileiro de Vigilância Sanitária - 23 a 27 nov. 2019. - 8º Congresso Brasileiro de Ciências Sociais e Humana em Saúde - 26 a 30 set. 2019
SARAMPO (1)
MENESES, C. A. R. et al. Molecular characterisation of the emerging measles virus from Roraima state, Brazil, 2018. Memórias do Instituto Oswaldo Cruz, Rio de Janeiro, v. 114, e180545, 2019.
(2) (3) (4) (5) (6) (7) (8) (9) (10)
VIEGAS, S. M. F. et al. A vacinação e o saber do adolescente: educação em saúde e ações para a imunoprevenção. Ciência e Saúde Coletiva, Rio de Janeiro, v. 24, n. 2, p. 351-360, Feb. 2019.
SANTOS, E. M. et al. Immunogenicity and safety of the combined vaccine for measles, mumps, and rubella isolated or combined with the varicella component administered at 3-month intervals: randomised study. Memórias do Instituto Oswaldo Cruz, Rio de Janeiro, v. 114, e180517, 2019.
DENG, X. et al. The first outbreak of measles virus caused by imported genotype D8 in Jiangsu province of China. Brazilian Journal of Infectious Diseases, Bahia, v. 23, n.1, p.66-69, Jan. 2019.
ESCALANTE, G. El retorno del sarampión en las Américas. Revista Médica del Uruguay, Montevideo, v. 35, n.2, p. 1-3, June 2019.
McMAHON, J.; MACKAY, I. M ; LAMBERT, S. B. Measles vaccine virus RNA in children more than 100 days after vaccination. Viruses, Basel, v. 11, n. 7, p.636, Jul. 2019.
McCLURE, D. L. et al. Similar relative risks of seizures following measles containing vaccination in children born preterm compared to full-term without previous seizures or seizure-related disorders. Vaccine, Kidlington, v. 37, n. 1, p. 76-79, 2019.
STREBEL, P. M; ORENSTEIN, W. A. Measles. New England Journal Medicine, Boston, v. 381, n.4, p. 349-357, Jul. 2019.
CHIODINI, J. Measles - Informing travellers about risks and prevention. Travel medicine and infectious diseases. Amsterdam, v. 29, p. 87-91, 2019.
PATEL, M. et al. Increase in measles cases - United States, January 1-April 26, 2019. MMWR: Morbidity and mortality weekly report, Atlanta, v. 68, n.17, p. 402-404, May 2019.
HANTAVIRUS (1) (2) (3) (4) (5)
MILHOLLAND, M. T. et al. The ecology and phylogeny of hosts drive the enzootic infection cycles of Hantaviruses, Viruses, Basel, v. 11, n.7, p. 671, Jul. 2019.
SARATHKUMARA, Y. D. et al. Exposure to Hantavirus is a risk factor associated with kidney diseases in Sri Lanka: a cross sectional study. Viruses, Basel, v. 11, n.8, p. 700, Jul. 2019.
BROCATO, R. L.; HOOPER, J. W. Progress on the Prevention and Treatment of Hantavirus Disease. Viruses, Basel, v. 11, n.7, p. 610, Jul. 2019.
ÇELEBI, G. et al. Dynamics of Puumala Hantavirus outbreak in Black Sea Region, Turkey. Zoonoses Public Health, Berlin, p. 1-15, Jul. 2019.
SALEHI-VAZIRI, M. et al. Hantavirus infection in Iranian patients suspected to viral hemorrhagic fever. Journal of medical virology, New York, v. 91, n. 10, p. 1737-1742, 2019.
(1) (2) (3) (4) (5)
QUINTANAL-VILLALONGA, A. et al. A patent review of FGFR4 selective inhibition in cancer (2007-2018). Expert Opinion on Therapeutic Patents v. 29, n. 6, p. 429-438, 2019.
LUO, J.; GONSALVES, G.; GREENE, J. Insulin for all: treatment activism and the global diabetes crisis. Lancet, London, v.393, n. 10186, p. 2116-2117, May. 2019.
CROCETTI, L. ; QUINN, M. T; SCHEPETKIN, I. A; GIOVANNONI, M. P. A patenting perspective on human neutrophil elastase (HNE) inhibitors (2014-2018) and their therapeutic applications. Expert Opinion on Therapeutic Patents, v. 29, n. 7, p. 555-578, 2019.
ABOY, M. et al. Mayo's impact on patent applications related to biotechnology, diagnostics and personalized medicine. Nature Biotechnology, New York, v. 37, n. 5, p. 513-518, 2019.
NICHOLSON PRICE II, W. ; RAI, A. K. How logically impossible patents block biosimilars. Nature Biotechnology, New York, v. 37, n. 8, p. 862-863, Aug. 2019.
Projeto Original
Conceição Carvalho - conceicao.carvalho@icict.fiocruz.br
Diones Ramos - diones.ramos@icict.fiocruz.br
Fátima Duarte - fatima.duarte@icict.fiocruz.br
Mônica Garcia - monica.garcia@icict.fiocruz.br
Rafael Cavadas - rcavadas@icict.fiocruz.br
Michele Nogueira -
Fernando Proença - fernando.proenca@icict.fiocruz.br
Programação Visual
Marcelo Vasconcellos - marcelo.vasconcellos@icict.fiocruz.br
Revisão de Conteúdo
Cristiane d'Avila - cristiane.davila@icict.fiocruz.br
Graça Portela - graca.portela@icict.fiocruz.br
Desenvolvimento de Sistema
Rosicler Magalhães- rosicler.magalhaes@icict.fiocruz.br